Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5201719
Max Phase: Preclinical
Molecular Formula: C23H24Cl2N8
Molecular Weight: 483.41
Associated Items:
ID: ALA5201719
Max Phase: Preclinical
Molecular Formula: C23H24Cl2N8
Molecular Weight: 483.41
Associated Items:
Canonical SMILES: Nc1nc(NCCc2c[nH]c3ccccc23)nc(N2CCN(c3cccc(Cl)c3Cl)CC2)n1
Standard InChI: InChI=1S/C23H24Cl2N8/c24-17-5-3-7-19(20(17)25)32-10-12-33(13-11-32)23-30-21(26)29-22(31-23)27-9-8-15-14-28-18-6-2-1-4-16(15)18/h1-7,14,28H,8-13H2,(H3,26,27,29,30,31)
Standard InChI Key: KMXCBWFCHIVUJL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 483.41 | Molecular Weight (Monoisotopic): 482.1501 | AlogP: 4.22 | #Rotatable Bonds: 6 |
Polar Surface Area: 98.99 | Molecular Species: BASE | HBA: 7 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.03 | CX LogP: 5.70 | CX LogD: 4.23 |
Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.38 | Np Likeness Score: -1.32 |
1. Kułaga D, Drabczyk AK, Satała G, Latacz G, Rózga K, Plażuk D, Jaśkowska J.. (2022) Design and synthesis of new potent 5-HT7 receptor ligands as a candidate for the treatment of central nervous system diseases., 227 [PMID:34710746] [10.1016/j.ejmech.2021.113931] |
Source(1):